Effect of oral L-arginine supplementation on blood pressure: a meta-analysis of randomized, double-blind, placebo-controlled trials
In close collaboration with Jens Juul Holst, we conducted a series of infusion studies on the satiety effects of other gut hormones including GLP-2 and PYY
Virta Health Announces First-of-its-Kind Peer-Reviewed Study Proving Its Approach Is an Effective Off-Ramp From GLP-1s for Sustained Weight Loss Company builds on nearly 10 years of GLP-1 experience, expanding its Sustainable Weight Loss solution to deliver medication-free and medication-assisted weight loss Virta Health has released first-of-its-kind, peer-reviewed data demonstrating the companys approach to personalized nutrition therapy results in sustained weight loss after the discontinuation of glucagon-like peptide-1 receptor agonists (GLP-1s), including Ozempic
There are no FDA-approved weight-loss IVs
Some common autoimmune conditions include Crohns disease, type 1 diabetes, rheumatoid arthritis, lupus, and multiple sclerosis
